Papp, K., Menter, A., Leonardi, C., Soung, J., Weiss, S., Pillai, R., & Jacobson, A. (2020). Long‐term efficacy and safety of brodalumab in psoriasis through 120 weeks and after withdrawal and retreatment: Subgroup analysis of a randomized phase III trial (AMAGINE‐1). Br J Dermatol.

Papp, K., A. Menter, C. Leonardi, J. Soung, S. Weiss, R. Pillai, et A. Jacobson. "Long‐term Efficacy and Safety of Brodalumab in Psoriasis Through 120 Weeks and After Withdrawal and Retreatment: Subgroup Analysis of a Randomized Phase III Trial (AMAGINE‐1)." Br J Dermatol 2020.

Papp, K., et al. "Long‐term Efficacy and Safety of Brodalumab in Psoriasis Through 120 Weeks and After Withdrawal and Retreatment: Subgroup Analysis of a Randomized Phase III Trial (AMAGINE‐1)." Br J Dermatol 2020.